Skip to main content

Table 8 TIL scores across different molecular subtypes of breast cancer

From: Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associates

 

Mean (SD)

Median (IQR)

P value

Luminal A

13.87 (15.44)

7.5 (17)

0.012

Luminal B

17.77 (18.50)

10 (25)

HER2-enriched

23.72 (21.84)

10 (30)

TNBC

20.91 (19.85)

12.5 (25)

  1. SD, standard deviation; IQR, interquartile range; HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us